RhythMedix has announced the release of its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is worn for extended remote monitoring without the need for an additional phone or communication device.
The technology enables rapid ECG analysis and reporting of cardiac abnormalities by RhythMedix’s team of certified technicians, who alert physicians if an arrhythmia of concern is detected. RhythmStar is now available with HeartTime on-demand telemetry mode, a platform that allows physicians to evaluate cardiac activity and expedite care via a telemedicine appointment, limiting the need for an in-person office visit.
“The novel wearable RhythmStar monitoring device offers increased patient compliance and allows for accurate assessment of cardiac rhythm in real time,” said Steven DaTorre, a clinical cardiologist at Cooper University Health Care, New Jersey, USA. “It also allows me to remain connected to my patients throughout their monitoring period, which may expedite a life-saving diagnosis.”
The one-piece device, with built-in 4G cellular technology, is the first wearable multi-modality cardiac monitor (Holter, Event and MCT) that connects patients and clinicians for improved patient care, RhythMedix said in a press release.
“We are excited to offer physicians and their patients our unique monitoring solution that improves patient compliance, helps accelerate diagnosis, and allows physicians to stay virtually connected to their patients with on-demand access to clinical data,” stated Brian Pike, president, chief operations officer and co-founder of RhythMedix. “We look forward to bringing this next-generation RhythmStar technology to physicians across the USA in 2021.”